SCHEMBL30452522

SCHEMBL30452522

COC(=O)c1nc(C)cc(Cc2ccc(F)cc2)c1O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RNASEH1 O60930 1/20 0.45
▸ HSP90AA1 P07900 2/20 0.44
▸ HSP90B1 P14625 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ EGLN1 Q9GZT9 1/20 0.42
▸ PLA2G2A P14555 1/20 0.41
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ GPR55 Q9Y2T6 1/20 0.39
▸ CES2 O00748 1/20 0.39
▸ FPR1 P21462 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257546 1.00 RNASEH1 (0.45) RNASEH1HSP90AA1HSP90B1ALDH1A1SMN1; SMN2
SCHEMBL30453338 0.85 EGLN1 (0.44) RNASEH1ALDH1A1EGLN1CNR2GPR55
SCHEMBL24257783 0.85 EGLN1 (0.44) RNASEH1ALDH1A1EGLN1CNR2GPR55
SCHEMBL24257549 0.82 EGLN1 (0.51) ALDH1A1SMN1; SMN2HPGDEGLN1CNR2
SCHEMBL24257458 0.81 EGLN1 (0.67) ALDH1A1EGLN1
SCHEMBL30452505 0.79 EGLN1 (0.51) ALDH1A1SMN1; SMN2HPGDEGLN1
SCHEMBL2146828 0.78 MAPT (0.44) RNASEH1HSP90AA1HSP90B1ALDH1A1SMN1; SMN2
Formic Acid SCHEMBL30453300 0.77 EGLN1 (0.62) ALDH1A1EGLN1
SCHEMBL22290167 0.76 NPSR1 (0.44) HSP90AA1HSP90B1ALDH1A1SMN1; SMN2HPGD
SCHEMBL754010 0.74 NPSR1 (0.47) RNASEH1ALDH1A1SMN1; SMN2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670131-A PHD inhibitor compounds, compositions, and methods of use 阿克比治疗有限公司 2023-08-29 — — CN disclosed
EP-4196466-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2023-06-21 — — EP disclosed
Send feedback